Drug Trial Radar · NCT06660069
A Study to Evaluate the Efficacy of a Stannous Fluoride Toothpaste With a Cetylpyridinium Chloride Mouthwash in Improving Gingival Health and Reducing Plaque Accumulation
Last checked: Nov 20, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
199
Actual
Start
Nov 18, 2024
Primary completion
Mar 11, 2025
Study completion Mar 11, 2025
Sponsor
- Lead sponsor
- HALEONIndustry
- Sponsor type
- Industry
- First posted
- Oct 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The aim of this study is to assess the ability of a marketed Cetylpyridinium Chloride (CPC) mouthwash alongside a marketed Stannous Fluoride (SnF2) toothpaste in improving gingival health and reducing plaque accumulation, compared to the use of a regular fluoride toothpaste alone in participants with clinically measurable plaque-induced gingivitis.
Conditions
- Dental Plaque
- Gingivitis
Interventions
Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)Drug
Toothpaste containing 0.454 percent (%) weight by weight (w/w) SnF2.
CPC Mouthwash (Parodontax Active Gum Health Mouthwash)Drug
Mouthwash containing 0.07% w/w CPC.
Regular Fluoride Toothpaste (Crest Cavity Protection)Drug
Toothpaste containing 0.243% w/w sodium fluoride.
Stannous Fluoride Toothpaste (Parodontax Complete Protection Toothpaste)Drug
Toothpaste containing 0.454% w/w SnF2.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Number of Bleeding Sites (NBS) at Week 12 (Toothpaste/Mouthwash Versus [vs.] Negative Control Toothpaste)Time frame: Week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Salus Research
Fort Wayne, Indiana
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.